Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07605975 · ClinicalTrials.gov registry record · NA
Measuring and Enhancing Creativity and Brain Flexibility in Adolescents With Depression
A NA study, sponsored by University of Minnesota.
- Completed
- Registry status
- NA
- Development phase
- 160
- Enrollment target
NCT07605975: Completed NA study, sponsored by University of Minnesota.
NCT07605975 is a NA study that has completed, run by University of Minnesota. The registered enrollment target is 160 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07605975, a NA study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- NA
- Development phase
- 160 participants
- Enrollment target
Study Summary
This research is designed to find out if engaging in creative activities will help adolescents with depression have more flexible thinking, start to see and appreciate their own talents, and develop a more positive view of themselves and their future.
Primary Outcome
The CDI (2) is a self-report questionnaire completed by child and parent separately. The Child CDI 2 is a 28-item measure of depression symptoms for youth ages 7-17. For each item, participants selected one of three choices that describe the severity of their symptoms over the past 2 weeks. Responses are: 0 (no symptoms), 1 (mild or probable symptoms), or 2 (definite symptoms). The 17-item Parent CDI 2, has four choices per item, ranging from 0 (not at all) to 3 (much or most of the time). For b
Interventions
- OTHER Creativity Camp
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2022-06-01 |
| Est. Completion | 2025-08-31 |
| Phase | NA |
What the finished NCT07605975 record still lists
NCT07605975 is an interventional study that assigns participants to a tested intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 1 intervention - of which Creativity Camp is the first listed.
NCT07605975 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07605975 about?
NCT07605975 is a clinical study titled "Measuring and Enhancing Creativity and Brain Flexibility in Adolescents With Depression". This research is designed to find out if engaging in creative activities will help adolescents with depression have more flexible thinking, start to see and appreciate their own talents, and develop a more positive view of themselves and their future.
What is the current status of trial NCT07605975?
This trial is currently completed. It is a NA study. The enrollment target is 160 participants. The study started on 2022-06-01. Estimated completion is 2025-08-31.
What interventions are being tested in trial NCT07605975?
The interventions under investigation include: Creativity Camp (OTHER).
Who is sponsoring clinical trial NCT07605975?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07605975's enrollment target sits among peer trials
160 628th of 2000 higher than 1,347 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00501826 · 160 participants · Phase 2
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- NCT00932139 · 160 participants · NA
Effect of Electro-Acupuncture on Blood Pressure
- NCT00992901 · 160 participants · Early Phase 1
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
- NCT01515527 · 160 participants · Phase 2
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI